Companies in the biopharma sector developing innovative solutions and technologies.
Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.
Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine.
Revere Pharmaceuticals develops a drug discovery and development platform targeting Rac1 and its genomic variants.
Pythia Labs is an LA-based start-up that crafts computational solutions to facilitate the discovery and design of biomolecular therapeutics.
Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.
Molcure is a high-speed, high-quality, high-variation antibody screening & design system combining biology, automation and bioinformatics
Captura Biopharma is an emerging biotechnology company engaged in the development and commercialization of heavy metal chelators.
Cerecor discovers, develops and commercializes neuroscience drugs.
Your premier CDMO for biologics drug development and manufacturing, from early development, to IND, to commercial stage.
Cytocom is a biopharmaceutical company focused on analogs that treat multiple diseases.
Formulary Insights help biopharmaceutical investors, marketers, and leaders understand and anticipate payer perceptions of their product.
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
Kantum Pharma is developing a specific AKI therapy to help critical care clinicians prevent hundreds of thousands of deaths from AKI.
EHP is a biotech company developing biotechnology and cannabinoids science and technology to treat incurable diseases.
RIN Institute is a bio-venture firm dedicated to the research and development of antibody-based medicines and external diagnostic drugs.
Rua Bioscience develops medicinal cannabis products.
The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.
Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked